Skip to main content

Post-IPO Equity Life Science Companies

Explore 104 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
104
Total Funding
$3.2B
Avg Funding
$127.3M
Cities
18

Export 104 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$250.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$20.3M
raised

Liberty Gold is an exploration-stage company that engages in the exploration, production, and development of gold and precious metals.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$30.0M
raised

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$100.0M
raised

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$3.8M
raised

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 104 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$690.0M
raised

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$150.0M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.3M
raised

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Guilford, United States
$50.0M
raised

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 104 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Würzburg, Germany
$23.2M
raised

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alameda, United States
$7.5M
raised

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$100K
raised

Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$4.0M
raised

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

Jul 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.1M
raised

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 104 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pittsburgh, United States
$972K
raised

Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Santa Ana, United States
$2.0M
raised

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$632.5M
raised

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 104 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$50.0M
raised

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Marlborough, United States
$43.5M
raised

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$361K
raised

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$40.0M
raised

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 104 companies

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 104 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked